Teleflex Incorporated (NYSE:TFX) Holdings Boosted by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. grew its holdings in Teleflex Incorporated (NYSE:TFX) by 35.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,875 shares of the medical technology company’s stock after purchasing an additional 1,527 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Teleflex were worth $1,053,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Cromwell Holdings LLC lifted its position in shares of Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after purchasing an additional 49 shares in the last quarter. Avior Wealth Management LLC lifted its position in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after buying an additional 101 shares in the last quarter. Ashton Thomas Securities LLC purchased a new stake in Teleflex in the 3rd quarter worth approximately $40,000. True Wealth Design LLC boosted its stake in shares of Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after buying an additional 166 shares during the period. Finally, GAMMA Investing LLC grew its holdings in shares of Teleflex by 131.1% during the 3rd quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock valued at $42,000 after acquiring an additional 97 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of Teleflex stock opened at $171.37 on Wednesday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The firm has a fifty day simple moving average of $179.58 and a 200-day simple moving average of $210.72. The stock has a market capitalization of $7.96 billion, a price-to-earnings ratio of 34.07, a PEG ratio of 1.72 and a beta of 1.16. Teleflex Incorporated has a 1-year low of $169.99 and a 1-year high of $256.85.

Wall Street Analysts Forecast Growth

TFX has been the subject of a number of research reports. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Royal Bank of Canada reduced their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Mizuho reduced their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Finally, Truist Financial dropped their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $252.50.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.